Evidence map›Paper›PMID 25700159›Full record

SynthesisPloS one2015

Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis.

Zoe Tolkien, Lynne Stecher, Adrian P Mander, Dora I A Pereira, Jonathan J Powell

11 registry-linked trialsOpen access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 11 registered trials, which are not on this map. Cited by 354 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
354citing papers in PubMed, 13 pooled it
36.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03562143 nacompletednot on this mapstarted 2018, after this paper: background citation

Daily vs Alternate Day Iron Supplementation for Pregnant Women With Iron Deficiency Anemia: A Randomized Controlled

TypeinterventionalSponsorIcahn School of Medicine at Mount SinaiRan2018 to 2020Enrolled88ConditionsIron Deficiency AnemiaArmsFerrous Sulfate
NCT03706638 nacompletednot on this mapstarted 2018, after this paper: background citation

Daily vs. Intermittent Iron Therapy in Iron Deficient Pregnant Patients: A Randomized Noninferiority Trial

TypeinterventionalSponsorUConn HealthRan2018 to 2020Enrolled46ConditionsIron Deficiency Anemia of PregnancyArmsFerrous Sulfate
NCT03836703 phase4completednot on this mapstarted 2019, after this paper: background citation

Doubling the Iron Dose VS Single Dose Iron Supplementation to Prevent Iron Deficiency Anemia (IDA) in Twin Pregnant Women: A Randomized Controlled Trial

TypeinterventionalSponsorAin Shams UniversityRan2019 to 2020Enrolled450ConditionsHematologic Pregnancy ComplicationsArmsFeroglobin single daily use, Feroglobin twice daily dose
NCT04608539 phase4completednot on this mapstarted 2021, after this paper: background citation

The Postoperative Iron in Cardiac Surgery (PICS-) Trial: A Randomised Clinical Trial Comparing the Efficacy of Single-, High-dose Intravenous Iron and Oral Iron for the Treatment of Anaemia Following Cardiac Surgery

TypeinterventionalSponsorMichael KremkeRan2021 to 2023Enrolled110ConditionsAnemia PostoperativeArmsFerric Derisomaltose, Ferrous sulfate, normal saline
NCT04778072 naunknown statusnot on this mapstarted 2018, after this paper: background citation

A Randomised, Double-blinded, Parallel Group Study to Demonstrate the Adherence and Efficacy of Different Doses of Iron Supplement in Subjects With or At-risk of Iron Deficiency With a History of Intolerance to Oral Iron

TypeinterventionalSponsorSolvotrin Innovations LtdRan2018 to 2021Enrolled60ConditionsPremenopause, Iron-deficiency, Iron Adverse Reaction, Iron Deficiency AnemiaArmsFerrous sulfate 14mg once daily, Ferrous sulfate 25mg once daily, Ferrous sulfate 25mg twice daily
NCT05060731 phase4not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Intravenous Ferric Carboxymaltose Versus Oral Ferrous Sulfate Replacement in Anaemia Due to Acute Nonvariceal Gastrointestinal Bleeding (FIERCE): Protocol of a Multicentre Randomised Controlled Trial

TypeinterventionalSponsorUniversity of PecsRan2025 to 2028Enrolled570ConditionsGastroIntestinal Bleeding, AnemiaArmsOral iron supplementation, Intravenous iron supplementation
NCT05590260 phase3completednot on this mapstarted 2023, after this paper: background citation

Prevention of Iron Deficiency Anemia Post-delivery (PRIORITY Trial): A Randomized Controlled Trial of the Global Network for Women's and Children's Health Research

TypeinterventionalSponsorNICHD Global Network for Women's and Children's HealthRan2023 to 2025Enrolled4,857ConditionsPostpartum AnemiaArmsFerric carboxymaltose (FCM) and folic acid tablets, Oral iron tablets and folic acid tablets
NCT05678647 nacompletednot on this mapstarted 2023, after this paper: background citation

Randomized Open Comparative Trial of Oral Sucrosomial Iron (SiderAl Forte®) and Oral Iron Sulphate (Duroferon®) to Blood Donors.

TypeinterventionalSponsorUppsala University HospitalRan2023 to 2026Enrolled120ConditionsBlood DonationArmsSucrosomial Iron, Iron Sulfate
NCT05826899 nacompletednot on this mapstarted 2023, after this paper: background citation

A Stable Isotope Study in Young Iron-depleted Thai Women to Evaluate the Bioavailability of an Oat Protein-based Iron Delivery System

TypeinterventionalSponsorThe Rainforest CompanyRan2023 to 2024Enrolled52ConditionsBioavailabilityArms54Fe SO4, 57Fe Oat-1, 58Fe Oat-2, 54 FeSO4 + Acai puree with honey, 57Fe Oat-1 + Acai puree with honey
NCT06521879 nacompletednot on this mapstarted 2022, after this paper: background citation

Improved Gastrointestinal Tolerance and Iron Status Via Probiotic Use in Iron Deficiency Anemia Patients Initiating Oral Iron Replacement

TypeinterventionalSponsorAntalya Training and Research HospitalRan2022 to 2023Enrolled295ConditionsIron Deficiency Anemia Treatment, Iron Deficiency AnemiaArmsLactobacillus plantarum 299v probiotic support
NCT07078630 nacompletednot on this mapstarted 2023, after this paper: background citation

Co-supplementation of Ferrous Iron With Formulated Curcumin Reduces Hepcidin Response in Trained Individuals: a Cross-over, Double-blinded, Placebo-controlled Human Intervention Study

TypeinterventionalSponsorUniversity of WestminsterRan2023 to 2024Enrolled10ConditionsIron Supplementation and Gastrointestinal Health, Iron DeficiencyArmsPlacebo, HydroCurc®, Ferrous sulphate 200mg oral tablet providing 65 mg of elemental iron
3 · Its place in the literature

Who cites it

354 citing papers in PubMed, 13 syntheses or guidelines pooled it, 760 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Daily oral iron supplementation during pregnancy.The Cochrane database of systematic reviews · 2024
    Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

294 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Zoe TolkienMRC Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge, United Kingdom.
Lynne StecherMRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge, United Kingdom.
Adrian P ManderMRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge, United Kingdom.
Dora I A PereiraMRC Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge, United Kingdom.
Jonathan J PowellMRC Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge, United Kingdom.
MRC Human Nutrition Research · GBMRC Biostatistics Unit · GB

Funding

Medical Research Council G0800860Medical Research Council MC_U105960399Medical Research Council MC_UP_1302/2Medical Research Council U105960399
6 · The paper itself

Abstract

backgroundThe tolerability of oral iron supplementation for the treatment of iron deficiency anemia is disputed.

objectiveOur aim was to quantify the odds of GI side-effects in adults related to current gold standard oral iron therapy, namely ferrous sulfate.

methodsSystematic review and meta-analysis of randomized controlled trials (RCTs) evaluating GI side-effects that included ferrous sulfate and a comparator that was either placebo or intravenous (i.v.) iron. Random effects meta-analysis modelling was undertaken and study heterogeneity was summarised using I2 statistics.

resultsForty three trials comprising 6831 adult participants were included. Twenty trials (n = 3168) had a placebo arm and twenty three trials (n = 3663) had an active comparator arm of i.v. iron. Ferrous sulfate supplementation significantly increased risk of GI side-effects versus placebo with an odds ratio (OR) of 2.32 [95% CI 1.74-3.08, p<0.0001, I2 = 53.6%] and versus i.v. iron with an OR of 3.05 [95% CI 2.07-4.48, p<0.0001, I2 = 41.6%]. Subgroup analysis in IBD patients showed a similar effect versus i.v. iron (OR = 3.14, 95% CI 1.34-7.36, p = 0.008, I2 = 0%). Likewise, subgroup analysis of pooled data from 7 RCTs in pregnant women (n = 1028) showed a statistically significant increased risk of GI side-effects for ferrous sulfate although there was marked heterogeneity in the data (OR = 3.33, 95% CI 1.19-9.28, p = 0.02, I2 = 66.1%). Meta-regression did not provide significant evidence of an association between the study OR and the iron dose.

conclusionsOur meta-analysis confirms that ferrous sulfate is associated with a significant increase in gastrointestinal-specific side-effects but does not find a relationship with dose.

Indexed as

Anemia, Iron-DeficiencyClinical Trials as TopicDatabases, FactualDietary SupplementsFerrous CompoundsGastrointestinal DiseasesHumansOdds RatioPlacebo EffectFerrous Compoundsferrous sulfate

Identifiers

PMID25700159
PMCPMC4336293
OpenAlexW2049123117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

and 5 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.